UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs

Cellular and molecular life sciences : CMLS, 2020-03, Vol.77 (6), p.1135-1152

2020

Link zum Volltext

Verfügbarkeit prüfen

USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.259-16, Article 259

2019

Link zum Volltext

Verfügbarkeit prüfen

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression

Journal of translational medicine, 2021-05, Vol.19 (1), p.209-209, Article 209

2021

Link zum Volltext

Verfügbarkeit prüfen

Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer

Cancer science, 2021-12, Vol.112 (12), p.4909-4919

2021

Link zum Volltext

Verfügbarkeit prüfen

LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network

Journal of experimental & clinical cancer research, 2023-08, Vol.42 (1), p.1-209, Article 209

2023

Link zum Volltext

Verfügbarkeit prüfen

METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma

Cell communication and signaling, 2022-03, Vol.20 (1), p.36-36, Article 36

2022

Link zum Volltext

Verfügbarkeit prüfen

Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer

Journal of experimental & clinical cancer research, 2022-10, Vol.41 (1), p.1-293, Article 293

2022

Link zum Volltext

Verfügbarkeit prüfen

A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma

Biomedicine & pharmacotherapy, 2019-10, Vol.118, p.109079-109079, Article 109079

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer

Journal of experimental & clinical cancer research, 2021-12, Vol.40 (1), p.1-386, Article 386

2021

Link zum Volltext

Verfügbarkeit prüfen

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma

Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.5764-5780

2023

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma

Frontiers in oncology, 2021-03, Vol.11, p.626858-626858

2021

Link zum Volltext

Verfügbarkeit prüfen

Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma

Frontiers in cell and developmental biology, 2022-11, Vol.10, p.977960-977960

2022

Link zum Volltext

Verfügbarkeit prüfen

The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics

Genomics (San Diego, Calif.), 2022-01, Vol.114 (1), p.125-137

2022

Link zum Volltext

Verfügbarkeit prüfen

METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification

Journal of cellular and molecular medicine, 2022-11, Vol.26 (22), p.5602-5613

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer

Journal of cellular and molecular medicine, 2019-03, Vol.23 (3), p.2064-2076

2019

Link zum Volltext

Verfügbarkeit prüfen

The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer

Journal of cellular and molecular medicine, 2021-12, Vol.25 (24), p.11244-11256

2021

Link zum Volltext

Verfügbarkeit prüfen

FBXO30 functions as a tumor suppressor and an E3 ubiquitin ligase for hZIP1‑mediated HIF‑1α degradation in renal cell carcinoma

International journal of oncology, 2023-03, Vol.62 (3), Article 40

2023

Link zum Volltext

Verfügbarkeit prüfen

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1[alpha] pathway and c-Myc expression

Journal of translational medicine, 2021-05, Vol.19 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice

BMC cancer, 2016-11, Vol.16 (1), p.892-892, Article 892

2016

Link zum Volltext

Verfügbarkeit prüfen

Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma

Urologic oncology, 2020-09, Vol.38 (9), p.740.e1-740.e9

2020

Link zum Volltext

Verfügbarkeit prüfen

miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression

Oncotarget, 2016-07, Vol.7 (30), p.48547-48561

2016

Link zum Volltext

Verfügbarkeit prüfen

METTL14-mediated N 6 -methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma

Cell communication and signaling, 2022-03, Vol.20 (1), p.36

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(13)
Cell Line, Tumor
(11)
Oncology
(10)
Tumors
(10)
Animals
(9)
Proteins
(9)
Cell Proliferation
(8)
Gene Expression
(8)
Bladder Cancer
(7)
Cell Biology
(7)
Gene Expression Regulation, Neoplastic
(7)
Antibodies
(6)
Cancer
(6)
Metastasis
(6)
Mice
(6)
Cell Migration
(5)
Medicine, Research & Experimental
(5)
Original
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs

USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression

Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer

LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network

METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma

Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer

A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma

Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma

Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma

The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics

METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification

Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer

The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer

FBXO30 functions as a tumor suppressor and an E3 ubiquitin ligase for hZIP1‑mediated HIF‑1α degradation in renal cell carcinoma

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1[alpha] pathway and c-Myc expression

Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice

Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma

miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression

METTL14-mediated N 6 -methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma

Suchergebnisse filtern